2010 Dec – 2012 Jun | $653k
West Africa Malaria Initiative (WAMI) Spanish Agency for International Development Cooperation (AECID), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Ogobara Doumbo | Africa, Western
West Africa Malaria Initiative (WAMI) Spanish Agency for International Development Cooperation (AECID), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Ogobara Doumbo | Africa, Western
EDCTP-Clinical Research and Product Development Fellow: Dr Amadou Hamidou Togo, MD, PhD, Université des Sciences Techniques et Technologiques de Bamako(USTTB), Faculty of Pharmacy (FAPH), Malaria Research and Training Center (MRTC) Grant Agreement number: TMA2019IF-2867 Grant Title: TMA2019 IF [ TOGO] Call for proposals: TMA2019 IF [ TOGO] The purpose of this Call for Proposals is to support researchers and members…
Efficacy and Safety of a newly registered Artemisinin-Based Combination (Pyronaridine-Artesunate -PYRAMAX®) for the treatment of uncomplicated malaria in African pregnant women (PYRAPREG) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Kassoum Kayentao | Dem. Rep. Congo, Mozambique, Burkina Faso, Gambia, Mali
Increasing Intermittent Preventive Treatment uptake through enhanced antenatal clinic service delivery to improve maternal and child health & assessing ANC data for routine monitoring in Mali U.S. President’s Malaria Initiative (PMI), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Kassoum Kayentao, Celia Woodfill | Mali
Malaria in pregnant is a public health problem in sub Saharan countries where 11 million pregnancies are exposed to malaria infection. Plasmodium falciparum in pregnant can cause adverse maternal health and poor birth outcomes. Artemisin-based Combination Therapy (ACT) used in treatment of uncomplicated Plasmodium falciparum malaria in pregnant women has the efficacy in Africa. The…
Optimization of Seasonal Malaria Chemoprevention (SMC) delivery and its effects on the acquisition of malaria immunity National Institute of Allergy and Infectious Diseases (NIAID), NIH, University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Alassane Dicko | Mali
Assessing safety, efficacy and transmission blocking properties of the new anti-malarial KAF156 combined with a new formulation of lumefantrine in children and adults with uncomplicated Plasmodium sp. malaria in West and Central Africa (WANECAM II) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Abdoulaye…